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In 2003 in the Netherlands, a new methicillin-resistant 
Staphylococcus aureus (MRSA) strain emerged that could 
not be typed with Sma1 pulsed-ﬁ   eld gel electrophoresis 
(NT-MRSA). The association of NT-MRSA in humans with 
a reservoir in animals was investigated. The frequency of 
NT-MRSA increased from 0% in 2002 to >21% after intensi-
ﬁ  ed surveillance was implemented in July 2006. Geographi-
cally, NT-MRSA clustered with pig farming. A case–control 
study showed that carriers of NT-MRSA were more often 
pig or cattle farmers (pig farmers odds ratio [OR] 12.2, 95% 
conﬁ  dence interval [CI] 3.1–48.6; cattle farmers OR 19.7, 
95% CI 2.3–169.5). Molecular typing showed that the NT-
MRSA strains belonged to a new clonal complex, ST 398. 
This study shows that MRSA from an animal reservoir has 
recently entered the human population and is now respon-
sible for >20% of all MRSA in the Netherlands.
M
ethicillin-resistant Staphylococcus aureus (MRSA) 
has traditionally been considered a nosocomial 
pathogen. However, for several years the number of re-
ports of so-called community-onset MRSA (CO-MRSA) 
has been rapidly increasing (1). CO-MRSA has no relation 
to healthcare and is usually associated with the presence 
of Panton-Valentine leukocidin toxin (PVL) and SCCmec 
types IV and V (2,3). In 2004 and 2005, some unexpected 
cases of MRSA were found in patients who were associated 
with pig farms (4,5). Genotyping showed that these MRSA 
isolates were nontypable by pulsed-ﬁ  eld gel electrophoresis 
(PFGE) and belonged to 1 spa type (t108). The aims of this 
study were to determine if nontypable MRSA (NT-MRSA) 
isolates are associated with pig farming and to compare the 
phenotypic, genotypic, and epidemiologic features of NT-
MRSA with those of typable MRSA strains.
Methods
National MRSA Database
The National Institute for Public Health and the Envi-
ronment (RIVM) is the national reference center for MRSA 
in the Netherlands (www.rivm.nl/mrsa). According to na-
tional guidelines, all microbiology laboratories send the 
ﬁ  rst isolate of newly identiﬁ  ed carriers of MRSA to RIVM. 
Strains are conﬁ  rmed to be MRSA by a Martineau PCR 
and by mecA PCR assay (6,7). Since 2002, all strains are 
typed by using PFGE (8), and the presence of PVL genes 
is determined (9).
Selection of Cases and Controls
Cases and controls were selected from the national 
MRSA database at RIVM. Case-patients were deﬁ  ned as 
persons carrying NT-MRSA who provided the ﬁ  rst isolate 
from a cluster of 1 particular referring laboratory (index-
patient) in the period January 2003 to September 2005. 
Cases were considered to be secondary to an index case 
when the strain was isolated within 3 months after the pre-
vious isolate with the same PFGE typing result. Controls 
were persons who carried MRSA that was typable with 
PFGE and who also fulﬁ  lled the index-patient deﬁ  nition. 
Controls were derived from the laboratories that provided 
cases and were selected at random. Twice as many controls 
as case-patients were selected.
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Collection of Epidemiologic Background Information
Data were collected by questionnaires that were sent 
to the referring laboratories. The questionnaire contained 
items about patient characteristics (birth date, sex, postal 
code, presence or absence of infection, hospital admis-
sion dates, profession, profession of partner, profession of 
parents, and contact with animals, e.g., pigs, cows, horses, 
chickens, cats, or dogs) and microbiologic data (isolation 
date, source of culture, medical specialty). All data were 
collected and entered into the database without our know-
ing whether it concerned a case or control.
Initially, 41 cases and 82 controls from 26 different 
laboratories were selected from the national database. The 
response rate was 98% (40 cases and 81 controls). During 
workup, 5 cases and 5 controls were excluded for the fol-
lowing reasons: the conﬁ  rmation test of the isolate indicat-
ed that it was not methicillin resistant (1 case), or the case 
did not fulﬁ  ll the case deﬁ  nition because it was not the ﬁ  rst 
case from a cluster (4 cases). Since 2 of these cases were 
from laboratories that had no other case in the study, the 
accompanying controls were excluded (n = 3). Two con-
trols were identiﬁ  ed outside the study period. Finally, 35 
cases and 76 controls from 24 different laboratories were 
included in the analysis.
Molecular Typing and Susceptibility Testing
All MRSA isolates were typed by PFGE (8). All iso-
lates from case-patients and 74 isolates from controls were 
typed by spa typing (10). Multilocus sequence typing 
(MLST) was performed on all case isolates, as well as on 
1 strain of each spa type of the control isolates (n = 37) 
(11). PCR of the staphylococcal chromosome cassette (SC-
Cmec) was performed according to Zhang et al. on all iso-
lates from case-patients and 74 isolates from controls (12). 
The presence or absence of PVL genes (lukS-PV/lukF-PV) 
was determined in all case isolates and in 71 control iso-
lates. The PVL genes were detected by PCR according to 
the method of Lina et al. (13). The susceptibility to antimi-
crobial agents was tested for 32 case isolates and 74 control 
isolates, according to CLSI guidelines that used Mueller-
Hinton agar and multipoint inoculation (14).
Statistical Analysis
Data were entered into an Excel database (Microsoft 
Windows version 97 SR-2, Redmond, WA, USA) and fur-
ther analyzed by using SAS (version 9.1) software pack-
age (SAS Institute Inc., Cary, NC, USA). Chi-square test 
and Fisher exact test for ordinal variables and Student t test 
for continuous variables were used for univariate analysis. 
Variables associated with both case-control status and the 
exposure (i.e., contact with pigs or cattle, respectively) with 
a p value <0.2 were included in the multivariate logistic re-
gression model. If such variables changed the risk estimate 
for >10%, they were left in the model. All statistical tests 
were 2-sided, and a p value <0.05 was considered statisti-
cally signiﬁ  cant.
Results
Epidemic Curve
The  ﬁ  rst NT-MRSA isolate was found in February 
2003. In subsequent years, an increasing number of NT-
MRSA isolates were found. The percentage of NT-MRSA 
relative to the total number of MRSA isolates in the Neth-
erlands that were unique or ﬁ  rst from a cluster rose from 
0% in 2002 to 5.5% in the ﬁ  rst half of 2006 and to >21% in 
the second half of 2006, after the introduction of intensiﬁ  ed 
surveillance in July 2006.
Geographic Distribution
Figure 1 shows the geographic distribution of NT-
MRSA and typable MRSA isolates, plotted over the den-
sity of the pig and human populations, respectively. The 
density of NT-MRSA isolates corresponds to the density of 
pig farming, whereas the density of typable strains corre-
sponds to the density of the human population. The density 
of cattle farms is more or less identical to the density of pig 
farms.
Epidemiologic Data
Results of the univariate analysis are shown in Table 
1. Comparable values were observed for the baseline char-
acteristics of sex and age. Case-patients more often lived in 
rural areas and indicated more frequent contact with pigs or 
cattle than did controls. Controls were more often associ-
ated with healthcare facilities.
Among case-patients, MRSA was more frequently 
found in clinical samples (an unexpected ﬁ  nding) compared 
with controls, whose MRSA was found more often by tar-
geted screening in nose, throat, and perineum. Among per-
sons infected by MRSA, respiratory tract infections were 
more frequent in case-patients, whereas skin and soft tissue 
infections predominated in controls.
Multivariate analysis that used a model with the vari-
ables describing type of residence (rural vs. other) and con-
tact with pigs, cattle, cats, and dogs (yes, no, or unknown) 
showed that contact with pigs and contact with cattle were 
independent statistically signiﬁ  cant variables. The adjusted 
odds ratios (OR) for pigs and cattle were 9.4 (95% conﬁ  -
dence interval [CI] 1.8–47.7) and 13.5 (95% CI 1.0–179.3), 
respectively.
Molecular Typing
Thirty-two of 35 case-patients had MLST sequence 
type (ST) 398; 1 had ST 9; and the remaining 2 had ST 752 
and 753, closely related to 398 (Figure 2). Among case-
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patients, the most frequent spa types were t108, t011, and 
t034 (Table 2). These MLST and spa types were not found 
among the controls. Twenty-two different STs and 37 dif-
ferent spa types were found in the controls (Table 2 and 
Figure 2).
SCCmec typing showed that in isolates from cases SC-
Cmec types III, IV, and V were found, whereas in isolates 
from controls all SCCmec types were found (Table 2). For 
11 cases and 33 controls, the SCCmec type could not be 
determined. There was no difference in the presence of the 
PVL genes (Table 2).
Antimicrobial Agent Susceptibility
Table 3 shows the percentage of strains that were re-
sistant to various antimicrobial agents. Isolates from case-
patients were signiﬁ  cantly more often resistant to doxycy-
cline and clindamycin than were isolates from controls.
Discussion
A new type of MRSA recently emerged in the Neth-
erlands. The ﬁ  rst isolate was found in 2003, and since 
then it has been found with increasing frequency. The 
geographic origin of NT-MRSA correlates with the den-
sity of pig populations. This association was conﬁ  rmed 
by the results from this case-control study, which show 
that NT-MRSA is signiﬁ  cantly related to contact with 
pigs. In addition, a signiﬁ  cant association was found with 
cattle. After multivariate analysis, contact with pigs and 
cattle were the only 2 signiﬁ  cant independent variables. 
Screening of a representative sample of pigs in the Neth-
erlands was recently performed and showed that nearly 
40% of the pigs were colonized with a comparable strain 
of MRSA (MLST 398) and that ≈80% of the pig farms 
were affected (15). The association between NT-MRSA 
and cattle was not expected when this study was initiated 
and needs further evaluation.
On the basis of the above-mentioned ﬁ  ndings, we con-
clude that this new MRSA strain is of animal origin (pigs 
and probably cows). Transmission of MRSA between ani-
mals and humans has previously been described, e.g., asso-
ciated with colonized companion animals, horses, and per-
sons who take care of them (16–19). However, the MRSA 
clones in these reports were known human clones, suggest-
ing human-to-animal transmission in origin. Baptiste et al. 
found speciﬁ  c PFGE clones in horses that were never ob-
served before (20). Until now, transmission of these clones 
to humans has not been reported.
We assume that this problem is not limited to the 
Netherlands. First, widespread dissemination in pigs in 
the Netherlands has been found. When one considers the 
intensive international transport of pigs, it is unlikely that 
this situation is limited to the Netherlands. Second, 3 of the 
case-patients came from abroad, 1 tourist and 2 adopted 
children from Asia. Also, MLST 398 was recently found 
in animals (pig, dog, and foal) and in humans in Germany 
(21). Finally, in Hong Kong Special Administrative Re-
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Figure 1. A) Number of nontypable methicillin-resistant Staphylococcus 
aureus (NT-MRSA) isolates per municipality received at the National 
Institute for Public Health and the Environment (RIVM), Bilthoven, 
the Netherlands, January 2003–June 2005. The background color 
represents the density of pigs per km2 in 2003. B) Number of typable 
MRSA per municipality received at the RIVM January 2003–June 
2005. The background color represents the population density per 
km2 (source: CBS Statline).MRSA of Animal Origin in Humans
gion, People’s Republic of China, MRSA with MLST 398 
has been found in 2 patients with bacteremia (22).
The origin of the current NT-MRSA situation is difﬁ  cult 
to elucidate. One earlier study can be found on carriage of 
S. aureus in pig farmers and pigs in France (23). It reported 
an increased carriage rate in pig farmers caused by trans-
mission of S. aureus from pigs that also carried MLST ST 
9 and 398. Further typing of the French ST 398 isolates at 
RIVM showed homology with the Dutch isolates. However, 
in the French study most of the MLST 398 strains were sus-
ceptible to β-lactam antimicrobial agents. The most likely 
explanation for the current ﬁ  ndings is that MLST 398 is a 
commensal strain in pigs, which originally was methicillin 
susceptible. As most NT-MRSA isolates were resistant to 
doxycycline, the spread is facilitated by the abundant use of 
tetracyclines in pig and cattle farming (15).
What are the implications of these ﬁ  ndings? Persons 
working or living in close contact with pigs or cows are 
at increased risk of becoming colonized and infected with 
MRSA. Infections can be severe, as is indicated by the 
hospital admission rate. Also, a case of endocarditis has 
been reported recently (24). At present, whether this strain 
is spreading further in the community is not clear. Before 
ﬁ  nal recommendations for control can be made, the current 
size of the reservoir in farm animals and in humans has to 
be determined at an international level.
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Table 1. Results of univariate analysis of case-control study, the Netherlands, February 2007* 
Cases Controls 
Variable No.
No. (%) or mean ± SD 
with variable  No.
No. (%) or mean ± SD 
with variable 
Odds ratio
(95% CI)† p value
Gender (male)  35 20 (57)  76 36 (47)  1.5 (0.7–3.3)  0.34
Age, y  35 42.7 ± 25.3  76 47.3 ± 24.7  0.37
Residence 35 75
  Rural area  14 (40)  6 (8)  7.7 (2.6–22.7)§  <0.01
  Urban area  20 (57)  66 (85) 
  Foreign country  1 (3)  3 (4) 
Contact with pigs  29 11 (38)  63 3 (5)  12.2 (3.1–48.6)  <0.01
Contact with cattle  29 7 (24)  63 1 (2)  19.7 (2.3–169.5)  <0.01
Unexpected MRSA  35 27 (77)  76 34 (45)  4.2 (1.7–10.4)  <0.01
Probable source  35 76
  Healthcare  5 (14)  39 (51)  0.01
  Foreign country  3 (9)  5 (7) 
  Other  12 (34)  10 (13) 
  Unknown  15 (43)  22 (29) 
Active infection  35 19 (54)  76 29 (38)  1.9 (0.9–4.3)  0.11
  Skin/soft tissue  10 (56)  24 (83)  0.3 (0.1–1.0)  0.05
 Airways  3  (17)  0
  Other  6 (28)  5 (17) 
Hospital admission  35 17 (49)  76 24 (32)  2.0 (0.9–4.6)  0.08
Hospital stay, d  16 18.9 ± 20.2  22 23.5 ± 30.9  0.60
*SD, standard deviation; CI, confidence interval; No., number of cases or controls for whom data are available. 
†Odds ratio was determined for rural area relative to urban area. 
Figure 2. Genetic relatedness of methicillin-resistant Staphylo-
coccus aureus from cases and controls, represented as a minimum 
spanning tree based on multilocus sequence typing (MLST) 
proﬁ   les. Each circle represents a sequence type, and numbers 
in the circles denote the sequence type. The size of the circle 
indicates the number of isolates with this sequence type. The 
number under and right of the lines connecting types denotes the 
number of differences in MLST proﬁ  les. The halos surrounding the 
circles indicate complexes of sequence types that differ by <3 loci.RESEARCH
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